A fourth Covid-19 booster dose may be needed to prevent a return to ‘pandemic phase’
Future waves of increased Covid-19 transmission in the US are still possible and may require another round of vaccinations.
By
Future waves of increased Covid-19 transmission in the US are still possible and may require another round of vaccinations.
ByMalaria is a vector-borne disease caused by parasites of the genus Plasmodium. Malaria is transmitted through the bite of the…
ByAs the Covid-19 pandemic stretches into its third year, the long-term effects of acute infection are beginning to become more…
BySubanalysis findings showed that the booster offered a 36-fold rise in SARS-CoV-2 Omicron neutralising titers.
The trial will enable the selection of the optimal dose for the Phase III trial study, anticipated to commence soon.
The initial portion of the trial will assess increasing doses of the NK1R+ MSCs in adult patients.
Due to efficacy, the Independent Data Safety Monitoring Committee advised halting the trial of sabizabulin early.
Assessing the safety, tolerability and humoral immunogenicity profile of the vaccine at day 56 is the study’s primary objective.